Contemporary Pharmacotherapy of Overactive Bladder

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Cox, Lindsey (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Rovner, Eric S. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
• Έκδοση: 1st ed. 2019.
• Θέματα: Urology.; Gynecology .; Gynecology.

 This text provides a comprehensive, state-of-the art review of pharmacotherapy for the overactive bladder, and serve as a valuable resource forclinicians, surgeons, and researchers with an interest in OAB. The early chapters will describe the pathophysiology of OAB, algorithm, and provide the readers with a practical guide for evaluating the OAB patient. The next section describes the unique challenges involved in the study of OAB and helps the reader navigate the complexities of the literature on the topic. All chapters are written by experts in their fields and include the most up-to-date scientific and clinical information. The text includes a review of the clinical guidelines for OAB, and a detailed description of the individual therapies, including antimuscarinics, Beta-3 agonists, (insert comma) and chemodenervation. Extensive tabulation of contemporary literature makes this a matchless resource that provides a detailed account of the current evidence for the use of each of these therapies. The text concludes with chapters on unique populations with OAB, and future directions in the research field. Contemporary Pharmacotherapy of Overactive Bladder unites a unique set of thought leaders in the field of voiding dysfunction to create a comprehensive resource that will be useful for a variety of clinicians who treat OAB, including urologists, urogynecologists, general gynecologists, family practitioners, and geriatricians. 

 Pathophysiology of Overactive Bladder -- Diagnosis of Overactive Bladder. The Placebo Effect in Overactive Bladder Syndrome -- Outcome Measures and Patient Expectations for Overactive Bladder -- National and International Guidelines in Overactive Bladder -- β3-Agonists for Overactive Bladder -- Combination Pharmacotherapy for Overactive Bladder -- Behavioral Therapy in Combination with Pharmacotherapy -- Pharmacotherapy for Nocturia -- Intravesical Chemodenervation and Toxins -- Other Treatment for Overactive Bladder, Including Intravesical -- Future Considerations in Overactive Bladder Pharmacotherapy -- Considerations in Pediatric Overactive Bladder -- Considerations in Male Overactive Bladder -- Considerations in the Medically Complex and Frail Elderly -- Individualizing Drug Therapy.